MCE - Delayed Quote EUR

Prim, S.A. (PRM.MC)

Compare
10.10
+0.10
+(1.00%)
As of 12:10 PM GMT+1. Market Open.
Loading Chart for PRM.MC
DELL
  • Previous Close 10.00
  • Open 10.10
  • Bid 10.00 x --
  • Ask 10.15 x --
  • Day's Range 10.10 - 10.10
  • 52 Week Range 9.50 - 12.10
  • Volume 348
  • Avg. Volume 5,946
  • Market Cap (intraday) 171.82M
  • Beta (5Y Monthly) 0.60
  • PE Ratio (TTM) 15.07
  • EPS (TTM) 0.67
  • Earnings Date Nov 4, 2024
  • Forward Dividend & Yield 0.45 (4.54%)
  • Ex-Dividend Date Jul 17, 2024
  • 1y Target Est 16.75

Prim, S.A. provides health technology, mobility, and health care products in Spain. The company offers collar, clavicle, armsling, hand and finger, shoulder, elbow, and wrist products. Its lower limbs products include calf brace, thigh, hip, knee, ankle, and foot related products. The company also provides shoulder and back supports, bands, corsets, hyperextension braces, and thoracic protectors. It offers its products under the OrthoPrim, AirMed, Airtex, Airtex Plus, aqtivo skin, aqtivo sport, ComforGel, ComforGel Lady, ComforSil, Essencial, Mottio, MyPrim, Neoprair, Neoprair One Size, PrimSpine, and Olium brands. Prim, S.A. was founded in 1870 and is headquartered in Móstoles, Spain.

www.prim.es

901

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PRM.MC

View More

Performance Overview: PRM.MC

Trailing total returns as of 11/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PRM.MC
0.29%
IBEX 35...
15.20%

1-Year Return

PRM.MC
1.13%
IBEX 35...
19.22%

3-Year Return

PRM.MC
23.43%
IBEX 35...
32.95%

5-Year Return

PRM.MC
6.51%
IBEX 35...
25.69%

Compare To: PRM.MC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PRM.MC

View More

Valuation Measures

Annual
As of 11/19/2024
  • Market Cap

    170.12M

  • Enterprise Value

    174.27M

  • Trailing P/E

    14.93

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.75

  • Price/Book (mrq)

    1.34

  • Enterprise Value/Revenue

    0.77

  • Enterprise Value/EBITDA

    6.42

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.02%

  • Return on Assets (ttm)

    4.12%

  • Return on Equity (ttm)

    9.14%

  • Revenue (ttm)

    227.57M

  • Net Income Avi to Common (ttm)

    11.43M

  • Diluted EPS (ttm)

    0.67

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    15.5M

  • Total Debt/Equity (mrq)

    15.07%

  • Levered Free Cash Flow (ttm)

    4.12M

Research Analysis: PRM.MC

View More

Company Insights: PRM.MC

Research Reports: PRM.MC

View More

People Also Watch